Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Targeting TLK2 with antisense oligonucleotides as a new strategy in acute myeloid leukemia.
Journal: Frontiers in oncology
Published: July 03, 2025
Type I MET inhibitors cooperate with PD-1 blockade to promote rejection of hepatocellular carcinoma.
Type I MET inhibitors cooperate with PD-1 blockade to promote rejection of hepatocellular carcinoma.
Journal: Journal for immunotherapy of cancer
Published: October 04, 2024
STAT6-targeting antisense oligonucleotides against solitary fibrous tumor.
Journal: Molecular therapy. Nucleic acids
Published: October 30, 2023
Cutaneous involvement with B-lineage acute lymphoblastic leukemia.
Journal: Leukemia & lymphoma
Published: November 10, 2011
Showing 1-4 of 4
Last Updated: 09/26/2026